A new study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending ...
Aug 31, 2023
0
89
Around 1 percent of the world's population lives with epilepsy; yet only 65 percent of epilepsy patients can manage their symptoms with medication. Currently, surgically removing the lesion in the brain responsible for the ...
Jan 17, 2022
0
187
A protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. Researchers led by Baylor College of Medicine also found that high levels of this protein, AKAP8, ...
Jan 27, 2020
0
172
Young patients with no risk factors for stroke may have an increased risk if they have contracted COVID-19, whether or not they are showing symptoms of the disease. Surgeons at Thomas Jefferson University and collaborators ...
Jun 4, 2020
0
8
A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new "universal" means of treating COVID-19.
Oct 18, 2022
0
38
Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis pioneered the use of radiation therapy—a strategy typically used against cancer—to treat patients with a life-threatening ...
Nov 28, 2023
0
66
We have a pretty good idea of where memory starts and ends—short-term memories form in the hippocampus and, if the situation calls for it, stabilize into long-term memories in the cortex. But what happens along the winding ...
Mar 30, 2023
0
3
Scientists at Nottingham Trent University, the University of Nottingham, Stanford University and the University of California and Cedars-Sinai Medical Center, Los Angeles, have found that the molecule "HNF4A" suppresses pancreatic ...
Jul 15, 2024
0
57
Researchers from Case Western Reserve University have identified a potential new approach to better controlling epileptic seizures.
May 19, 2021
0
103
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis (MS), a chronic, debilitating disorder that damages myelin forming cells ...
Oct 17, 2013
0
0
